AdvanCell is a clinical-stage radiopharmaceutical company developing targeted alpha therapies to improve cancer survival and quality of life. (Its in house alpha isotope generator ensures the reliable and scalable supply of isotope, the greatest unmet need in targeted alpha therapy.)

Sector
Radiopharmaceuticlas, Oncology
Origin
University of Newcastle
STAGE
Series C
Partnered In
2024
Founded by
Andrew Adamovich
"

  • "

  • "

  • "

  • "